G7 plan for trusted AI & U.S. restrictions hit Anthropic - News (Jun 18, 2026)

Allied leaders are quietly discussing a way to regain access to America’s most powerful AI—after one top lab suddenly shut foreigners out, citing national security. Welcome to The Automated Daily, top news edition. The podcast created by generative AI. I’m TrendTeller, and today is June 18th, 2026. Here’s what’s moving the world—across AI, health, space, and geopolitics.

G7 plan for trusted AI

We’ll start with the G7 in Evian-les-Bains, where diplomats say leaders and officials have been debating a “trusted partners” scheme for advanced AI. The idea: create a vetted lane so selected allied countries—or even specific companies—can access high-end U.S.-built models that are increasingly being treated like strategic assets. This comes right after Anthropic reportedly disabled foreign access to its most advanced systems, following an order from President Donald Trump to block foreign nationals on national security grounds. Allies raised the issue with U.S. Commerce Secretary Howard Lutnick on the summit sidelines, looking for a workable path that still respects Washington’s security concerns. Supporters say broader allied access could strengthen cybersecurity—especially against rivals like China. But critics warn that the same AI that can find software weaknesses could also help weaponize them. The White House says it’s staying closely engaged with allies, while keeping security as the priority. And in a sign of how central this has become, executives from Anthropic, OpenAI, and Google are expected to brief leaders on regulation, infrastructure, and networks—while the EU is pushing for access to study risks firsthand.

U.S. restrictions hit Anthropic

Staying with AI, Nvidia CEO Jensen Huang is urging the public—and policymakers—to accept that AI is rapidly becoming part of everyday life, and to shape it with what he called “new social norms.” Speaking with the Associated Press in Sherman, Texas, Huang argued that people shouldn’t avoid AI out of fear, because it can help close skill gaps—letting more people do sophisticated work without years of technical training. He also acknowledged the big worries: job disruption and broader safety risks. His message was basically that the industry has an obligation to respond to critics, not dismiss them. And he called for government regulation and safety standards, with national security front and center. When the person whose chips power a large portion of the AI boom says we need rules and guardrails, it’s a reminder that the next phase isn’t just about speed—it’s about governance.

Nvidia calls for AI norms

And here’s a headline that underscores how intense the AI race has become: Noam Shazeer, a major Google engineering leader behind the Gemini models, is leaving Google to join OpenAI. Shazeer isn’t just another executive. He co-authored the 2017 research that introduced transformers, the foundation for systems like ChatGPT, Gemini, and Claude. The move is especially striking because Google only recently spent billions—through a Character.AI licensing and rehiring deal—to bring him back and put him in a key leadership role. In plain terms: even the biggest tech companies are struggling to keep top AI minds in-house, and shifts like this can influence what gets built, how fast, and where the next breakthroughs land.

Google AI leader joins OpenAI

Now to a very different kind of AI story—one that’s about who benefits financially. Senator Bernie Sanders has introduced legislation that would give the public direct ownership stakes in major AI companies. His proposal centers on a sovereign wealth fund financed by a one-time stock-based tax on large AI firms above a revenue threshold. The fund would then pay dividends to Americans, while also using voting power to influence corporate decisions and potentially block actions deemed harmful. Whether this goes anywhere in Congress is an open question. But it taps into a real anxiety: that AI could deliver enormous productivity and profits—while concentrating wealth and control in a handful of firms. This idea, in one form or another, is gaining traction across the political spectrum. The big debate is how far government should go: light-touch redistribution, or direct ownership and oversight.

Sanders pitches public AI shares

Canada is also weighing tighter rules around tech—this time aimed at young people. The federal government is preparing potential restrictions on social media use for children under 16 as early as this fall. A media consultant speaking with CTV said limits could help, but warned they won’t fix everything by themselves. He argued that what’s really needed is a reset in media literacy—so kids understand how platforms shape attention, privacy, and behavior. One detail that stood out: some young people are already asking parents not to post or tag them, reflecting rising concerns about permanent digital footprints created long before a child can consent. Even if a ban arrives, enforcement at school and consistency across families and educators could be the real test.

Canada considers under-16 social ban

To health news now, starting with a major public-health win. A landmark study in England found that girls vaccinated against HPV at ages 12 to 13 had an almost zero risk of dying from cervical cancer before age 30. From 2020 through 2024, researchers found no recorded cervical cancer deaths among women aged 20 to 24—where more than twenty deaths would have been expected without vaccination. The takeaway is simple and powerful: preventing HPV prevents cervical cancer, and the impact shows up faster than many expected. But officials warn this success depends on high uptake, and vaccination rates are still below the World Health Organization’s target. Catch-up programs and easier testing are being pushed, and health experts emphasize that screening still matters for adults, even in a vaccinated population.

HPV vaccine slashes cervical deaths

Another medical development is drawing attention for a disease that’s notoriously hard to treat: pancreatic cancer. A University of Virginia oncologist highlighted results for an experimental pill called daraxonrasib, where a large clinical trial found survival more than doubled for some patients with advanced disease. In the study, people on second-line chemotherapy lived around six and a half months on average, compared with just over thirteen months for those who received the new drug. That’s a meaningful jump in a cancer where options can be limited. The bigger reason researchers are excited is that most pancreatic cancers involve KRAS mutations—long considered extremely difficult to target. The treatment isn’t commercially available yet, but it’s awaiting expedited FDA review and could reach patients within months. Side effects like rash were reported, and doctors stress they need prompt management—but the idea of an effective oral option is a hopeful shift for many patients.

Pancreatic cancer pill doubles survival

From medicine to Mars: NASA has selected Relativity Space to build a spacecraft, launch it, and send it to Mars for a mission called Aeolus. The company is now led by former Google executive chair Eric Schmidt. NASA will provide the scientific instruments, while Relativity supplies the spacecraft and launch—mirroring the public-private approach NASA has used for cargo missions and lunar landers. Aeolus is designed to deliver daily, global views of Martian dust, winds, and temperatures—data that could make future landings safer and support eventual human missions. The catch is the timeline and the risk. The mission targets a 2028 launch, and Relativity’s big rocket, Terran R, hasn’t flown yet. If it works, it could be a landmark: a private company reaching Mars with a science mission, and a new kind of competition in deep space.

NASA picks Relativity for Mars

And finally, a milestone in brain-computer interfaces: Paradromics and University of Michigan Health reported the first human implantation of the Connexus system in an FDA-approved early feasibility study. The goal is straightforward, and profound—help people with severe motor impairments regain communication, including speech and computer control. The first participant, a woman with motor neuron disease, will be followed for years as researchers evaluate safety and real-world performance. This doesn’t mean instant mind-reading or consumer gadgets. It means careful clinical steps toward restoring basic human abilities that illness can take away—and that’s why this matters.

First long-term Connexus BCI implant

Before we wrap, a quick update from the G7 on geopolitics: Canada’s Prime Minister Mark Carney says he has seen a tentative U.S.-Iran framework aimed at ending the war and, in his view, closing off Iran’s path to a nuclear weapon. Public details remain limited, but Carney described it as performance-based and backed by incentives, with a 60-day ceasefire extension while negotiators work toward something more permanent. Major complications remain—especially reported conditions tied to Israel and Lebanon that Israel has already rejected. Carney also suggested that if the Strait of Hormuz reopens more reliably, it could ease energy pressures that have rippled through the global economy. For now, the world is watching to see whether the ceasefire turns into a durable agreement—or just a pause.

That’s the Top News Edition for June 18th, 2026. The through-line today is trust—who gets access to powerful AI, how societies set new rules around it, and how institutions try to turn breakthroughs in health and space into real-world results. If you’re listening on a platform that supports it, follow the show so you don’t miss tomorrow’s rundown. I’m TrendTeller, and this was The Automated Daily.

G7 plan for trusted AI & U.S. restrictions hit Anthropic - News (Jun 18, 2026)

Our Sponsors

Today's Top News Topics